Filed: 2/7/2025ACC: 0001104659-25-010583
📋 What this filing means
REGENERON PHARMACEUTICALS, INC. filed this quarterly 13F‑HR report disclosing 6 equity positions with a total reported market value of $1.09B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
6
Positions
$1.09B
Total AUM (reported)
10.57M
Total Shares
Allocation by class
COMMON STOCK$1.09B100.0%
Portfolio Concentration
Top 3$1.09B99.8%
4–10$1.95M0.2%
Top 3 weight
99.8%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 10.57M
Sole
Full voting authority
10.57M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole6
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings6
Rows:
Alnylam Pharmaceuticals, Inc.
SOLEShares4.44M
TypeSH
Market value$1.05B
95.54%
Sole
4.44M
Shared
0.00
None
0.00
Intellia Therapeutics, Inc.
SOLEShares3.70M
TypeSH
Market value$43.18M
3.94%
Sole
3.70M
Shared
0.00
None
0.00
2seventy bio, Inc.
SOLEShares1.25M
TypeSH
Market value$3.69M
0.34%
Sole
1.25M
Shared
0.00
None
0.00
Adicet Bio, Inc.
SOLEShares968.18K
TypeSH
Market value$931.4K
0.09%
Sole
968.18K
Shared
0.00
None
0.00
Adverum Biotechnologies, Inc.
SOLEShares180.91K
TypeSH
Market value$844.8K
0.08%
Sole
180.91K
Shared
0.00
None
0.00
bluebird bio, Inc.
SOLEShares21K
TypeSH
Market value$175.1K
0.02%
Sole
21K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Alnylam Pharmaceuticals, Inc.SOLE | Common Stock | 4.44M | SH | $1.05B 95.54% | 4.44M | 0.00 | 0.00 |
Intellia Therapeutics, Inc.SOLE | Common Stock | 3.70M | SH | $43.18M 3.94% | 3.70M | 0.00 | 0.00 |
2seventy bio, Inc.SOLE | Common Stock | 1.25M | SH | $3.69M 0.34% | 1.25M | 0.00 | 0.00 |
Adicet Bio, Inc.SOLE | Common Stock | 968.18K | SH | $931.4K 0.09% | 968.18K | 0.00 | 0.00 |
Adverum Biotechnologies, Inc.SOLE | Common Stock | 180.91K | SH | $844.8K 0.08% | 180.91K | 0.00 | 0.00 |
bluebird bio, Inc.SOLE | Common Stock | 21K | SH | $175.1K 0.02% | 21K | 0.00 | 0.00 |